| The White House is weighing whether to try to salvage or abandon Heidi Overton’s nomination to lead the Food and Drug Administration, as skepticism from some Republicans threatens to derail her confirmation ahead of a key committee vote Wednesday, according to my WaPo colleagues Rachel Roubein and Dan Diamond. It comes as Overton, who serves as deputy director of the White House’s Domestic Policy Council, faces opposition on several fronts. This includes anger from some Make America Healthy Again advocates who view her as too friendly to corporate interests, and a campaign on the streets of Washington, D.C., targeting her over policies involving abortion and access to flavored vapes. Key Republican senators on the Senate Health, Education, Labor and Pensions (HELP) Committee have expressed concern that Overton would move to restrict access to medication abortion, while an antiabortion group is seeking commitments that she would enact stricter requirements for the drugs prior to her confirmation. Now federal officials have started discussing potential alternative candidates, two people familiar with the matter told my colleagues at The Post. They spoke on the condition of anonymity to discuss a personnel matter. While the White House didn’t immediately return The Post’s request for comment, the White House’s social media account on Monday afternoon shared a column that urged Overton’s confirmation. Over the weekend, Sen. Bill Cassidy (R-Louisiana), a physician who leads the HELP Committee and has questioned Overton about her views on vaccine policy, said he still had “questions” about her ability to serve. Overton stood by President Donald Trump while he signed an executive order that called for reducing the number of vaccines that children receive and other changes to vaccine policy opposed by major medical groups. While the panel is scheduled to vote on whether to advance her nomination to the full Senate on Wednesday morning, Cassidy said on CBS’s “Face the Nation” that he couldn’t “tell you the outcome of that vote right now.” The political math: Republicans hold just a one-seat majority on the HELP Committee, meaning a single GOP defection could sink Overton’s nomination if Democrats oppose her. → A tidbit from the story: The “Heidi Vaperton” campaign-style signs urging senators to vote against Overton’s confirmation are the product of a group dubbed “Health in Office,” Dan has uncovered. A spokesperson for the group, Jennifer Kay, declined to share the activists’ identities but said they were “nonpartisan” and worried about Trump’s health agenda. Read the full story: “White House weighs next steps for FDA nominee who faces bipartisan pushback.” The loss of the United States’ measles-elimination status is giving Democrats another opening to challenge Health Secretary Robert F. Kennedy Jr. over his handling of public health, with the incoming congressional majority preparing a broader oversight push into his vaccine policies. Democrats had already been pressing Erica Schwartz, leader of the Centers for Disease Control and Prevention, for answers about the administration’s response to the measles outbreak and its efforts to overhaul childhood vaccine recommendations. But the loss of measles-elimination status has added fresh urgency to those demands. With Democrats set to take control of both chambers next year, Kennedy is likely to face more aggressive scrutiny. Lawmakers have called for him to resign or be fired, and some have raised the prospect of impeachment. The Democratic Doctors Caucus on Monday said the decision reflected the consequences of Kennedy’s public comments and actions on vaccines. “Under his leadership, deadly, preventable diseases like measles are back,” the group of lawmakers, which includes Reps. Ami Bera (D-California), an internal medicine specialist, Kim Schrier (D-Washington), a pediatrician, and Maxine Dexter (D-Oregon), a pulmonologist. The caucus “will do everything we can with our new Democratic majorities in Congress to hold RFK Jr. accountable, rebuild our public health infrastructure, and save lives,” the statement says. In a separate statement, Schrier also called on Kennedy to resign, warning that he would otherwise face congressional oversight. “Children’s lives are on the line,” she said. Democratic Sen.-elect Annie Andrews of South Carolina responded to news of the U.S. losing its measles elimination status by saying, “No child should have to suffer from a disease we know how to prevent because of political hubris in Washington.” Andrews, a pediatrician, has previously said that Congress should impeach and remove Kennedy from his post. Kennedy has defended his tenure, telling lawmakers in April that the U.S. has “done better in preventing [measles] than any country in the world” and pointed to high case counts in Canada and Mexico. - Last week, Centers for Disease Control and Prevention Director Erica Schwartz said that a change in status wouldn’t prompt a change in administration strategy.
“Let’s say we did lose our measles-elimination status,” Schwartz told Reuters. “We’re going to be doing the same exact thing that we’ve been doing today, which is working with the states.” She mirrored those comments at the Milken Institute Future of Health Summit on Thursday, saying states should be taking the lead on the response to the outbreaks, alongside additional federal aid. Schwartz said that the federal government is offering support — having provided $100 million to states since the measles outbreak began as well as on-the-ground assistance and laboratory support. Sen. Michael Bennet (D-Colorado) called on Schwartz to resign, accusing her of offering “excuses and complacency” rather than mounting an urgent response to protect children, and claiming she has failed to resist Kennedy’s vaccine policy overhaul. The resurgence of the illness is forcing doctors to relearn how to recognize and treat a disease that has been largely absent from medical practice since the U.S. eliminated measles in 2000. And the consequences could extend well beyond the current outbreak that so far has logged more than 5,400 cases, hundreds of hospitalizations and at least 10 deaths. Nationally, 41 percent of measles cases this year have been among adults age 20 and older, up from 29 percent last year, according to data from the Centers for Disease Control and Prevention. In Pennsylvania, at least 101 pregnant women have contracted the disease, and doctors estimate nearly two dozen babies have been born with measles or acquired it shortly after delivery, reports Lena H. Sun in The Washington Post newsroom. - What this means for doctors: Physicians have limited modern research to guide them on the potential long-term effects of those infections, even when patients recover.
“There is a tremendous amount of what I would describe as learning on the fly,” John Goldman, an epidemiologist at UPMC Harrisburg, told Lena. In more than three decades as a doctor, he’d previously only seen two measles cases. He’s now helped to care for roughly 50 patients with the highly contagious disease in a single year. Read the full story: “Surging measles cases are forcing doctors to treat conditions they’ve never seen.” And, since babies rely on passive immunity from their mothers, which begins to diminish around six months — yet often receive their first round of vaccination against measles around 12 months to 15 months — they’re left vulnerable to infection as overall vaccination rates have declined nationwide. “The community protection we took for granted is gone, and U.S. moms now must live in fear that their babies will be harmed by a completely preventable disease, while they do everyday tasks,” Jerome Adams, who served as surgeon general during Trump’s first term, wrote in a social media post. Two infants have died from measles in November alone, which former CDC director Rochelle Walensky and Benjamin Rader, scientific director of the innovation group at Boston Children’s Hospital, argue in a Post op-ed Monday means that children should now be given an extra dose at 6 months of age. Walensky and Rader say the shot has been shown to be safe in babies at least 6 months old, but the earlier “zero dose” has generally only been to younger children traveling internationally. - What measles cases mean for states and localities: Measles outbreaks also carry a significant financial burden.
A Johns Hopkins University analysis of outbreaks across 18 states between 2000 and 2025 estimated an average cost of about $43,000 per case, including medical expenses, public health response and lost productivity — though figures can vary widely depending on factors including the location and number of cases. Earlier this year, The Post found that containing a measles outbreak in the Denver area cost nearly a half-million dollars. Eric Cantor, who took the helm of the Pharmaceutical Research and Manufacturers of America as CEO last week, is continuing to revamp the pharmaceutical industry’s top lobbying group. The latest change: He’s eliminated a C-suite-level communications post. Robert Zirkelbach said that he will be leaving PhRMA on Nov. 30. “With the arrival of a new CEO, the Chief Public Affairs Officer position is being eliminated as part of the leadership transition,” Zirkelbach wrote in a LinkedIn post, calling out his work to help to “reshape the national debate over PBMs,” among other issues. In a farewell email that I obtained, Zirkelbach said he’s taking some time to “consider [his] options.” “I’ve always been drawn to big challenges, and I’m looking forward to taking on new ones,” he wrote. Zirkelbach, who served nearly 10 years at the organization over two separate stints, rejoined in 2023 to lead its public affairs operation, in addition to heading up its strategic initiatives efforts. Cantor recently named Kristi Way to a newly created position involving strategy and operations. Way previously served as Cantor’s chief of staff and senior adviser at Moelis & Company. Rep. Mike Kennedy (R-Utah) will take over as co-chair of the GOP Doctors Caucus in the next Congress, giving the group a new physician’s voice in its leadership. Members of the group unanimously elected Kennedy to serve alongside Rep. John Joyce (R-Pennsylvania), replacing Rep. Greg Murphy (North Carolina), who spent two years as co-chair and recently lost his reelection bid to Democrat Raymond Smith. Four additional members of the GOP Doctors Caucus won’t be returning next Congress, including three who lost their seats. The group, originally formed in 2009, can play a significant role in developing Republican health policy. Kennedy, a family physician, said in a statement that he wants to “elevate the influence of the Doc Caucus and give our members the meaningful voice and seat at the table they deserve in shaping health care policy.” “CDC declined to alert risk of measles in pregnancy. A journal released the data.,” Lena H. Sun reports at The Post. “The surprising new face of the MAHA-MAGA alliance: Stephen Miller,” reports The Post’s Rachel Roubein. “States can delay controversial Medicaid work requirement for six months,” Daniel Wu reports at The Post. “The link between microplastics and one of the deadliest cancers, and what to do,” The Post’s Shannon Osaka reports. “F.D.A. Rejects Closely Watched Lung Cancer Drug From China,” reports Rebecca Robbins at the New York Times. “Powerful Trump Allies Aided a Chinese Vape Operation,” Liz Essley Whyte and Michelle Hackman report at the Wall Street Journal. This newsletter is published by WP Intelligence, The Washington Post’s subscription service for professionals that provides business, policy and thought leaders with actionable insights. WP Intelligence operates independently from The Washington Post newsroom. |